Re:: Integrin β3 Leu33Pro homozygosity and risk of cancer

被引：7

作者：

Jin, QR ^{[1
]}

Hemminki, K

Grzybowska, E

Klaes, R

Söderberg, M

Försti, A

机构：

[1] Karolinska Inst, Novum, Dept Biosci, SE-14157 Huddinge, Sweden

[2] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany

[3] Marie Sklodowska Curie Inst, Ctr Oncol, Dept Tumor Biol, Gliwice, Poland

[4] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany

[5] Huddinge Hosp, Dept Pathol, S-14186 Huddinge, Sweden

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 03期

关键词：

D O I：

10.1093/jnci/djh032

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：234 / 235

页数：2

共 7 条

[1] Defective platelet response to arachidonic acid and thromboxane A2 in subjects with PlA2 polymorphism of β3 subunit (glycoprotein IIIa) [J].

Andrioli, G ;

Minuz, P ;

Solero, P ;

Pincelli, S ;

Ortolani, R ;

Lussignoli, S ;

Bellavite, P .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (04) :911-918

[2] Genetic polymorphisms of platelet adhesive molecules:: association with breast cancer risk and clinical presentation [J].

Ayala, F ;

Corral, J ;

González-Conejero, R ;

Sánchez, I ;

Moraleda, JM ;

Vicente, V .

BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (02) :145-154

[3]

BJOESEN SE, 2003, J NATL CANCER I, V95, P1150

[4] Integrin activation controls metastasis in human breast cancer [J].

Felding-Habermann, B ;

O'Toole, TE ;

Smith, JW ;

Fransvea, E ;

Ruggeri, ZM ;

Ginsberg, MH ;

Hughes, PE ;

Pampori, N ;

Shattil, SJ ;

Saven, A ;

Mueller, BM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1853-1858

[5] Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer [J].

Försti, A ;

Jin, QR ;

Grzybowska, E ;

Söderberg, M ;

Zientek, H ;

Sieminska, M ;

Rogozinska-Szczepka, J ;

Chmielik, E ;

Utracka-Hutka, B ;

Hemminki, K .

CARCINOGENESIS, 2002, 23 (08) :1315-1320

[6] Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population [J].

Hofmann, W ;

Scherneck, S ;

Horn, D ;

Paepke, S ;

Grumann, M ;

Wappenschmidt, B ;

Kempe, A ;

Friedl, W ;

von der Groeben, C ;

Schmutzler, RK ;

Betz, B ;

Goecke, TO ;

Bodden-Heidrich, R ;

Beckmann, MW ;

Niederacher, D ;

Krueger, M ;

Schaefer, D ;

Jordan, J ;

von Minckwitz, G ;

Arnemann, J ;

Botz, J ;

Bartram, CR ;

Voigtländer, T ;

Bastert, G ;

Henningsen, P ;

Arnold, NK ;

Gross, E ;

Schlegelberger, B ;

Gerber, WD ;

Kiechle, M ;

Thamm, B ;

Kraus, H ;

Langanke, D ;

Voigt, T ;

Froster, UG ;

Brandau, O ;

Golla, A ;

Vodermeier, A ;

Nestle-Krämling, C ;

Meindl, A ;

Preisler-Adams, S ;

Dwornic-zak, B ;

Jebali, P ;

Jakisch, C ;

Horst, J ;

Eberhardt, E ;

Volm, T ;

Bochum, S ;

Tamulionyte, L ;

Grill, HJ .

INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (04) :472-480

[7] The future of association studies of common cancers [J].

Houlston, RS ;

Peto, J .

HUMAN GENETICS, 2003, 112 (04) :434-435

← 1 →